@FierceMedDev: TriVascular lands $40M round for aortic stent grafts. Story | Follow @FierceMedDev
@MarkHFierce: Medtronic's latest earnings report comes out on Nov. 19. | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Brain tumors succumb to drugs delivered via bone scaffold. More | Follow @MichaelGFierce
> A court recently found the German safety standards firm TUV Rheinland liable in a global scandal over substandard breast implants made by the now-defunct French firm PIP. Story
> Atossa Genetics ($ATOS) said it had a fruitful pre-510(k) submission meeting with the FDA regarding its ForeCYTE Breast Pump and patient kit, potentially overcoming a warning letter that chided the company for marketing the now-recalled cancer diagnostic device without agency clearance. Item
> Corgenix has sealed a collaborative diagnostic test development deal with Zalgen Labs. Item
> A South Carolina startup envisions using magnets to lock and unlock a knee replacement system to help patients have more mobility. Story
> FBC Device gained a CE mark for its new spinal fusion plant and will launch the device in Europe and Canada. Item
Biotech News
@FierceBiotech: Tufts: Big Pharma bets its future on a swelling pipeline of biologic. Article | Follow @FierceBiotech
@JohnCFierce: AbbVie scores SVRs of 95% and 98% for GT1a and GT1b groups in first PhIII hep C study. More | Follow @JohnCFierce
@DamianFierce: FierceBiotech, coming soon to an Android near you. (Get your iPhone/iPad version in the iTunes store.) Download | Follow @DamianFierce
@EmilyMFierce: Federal government to transfer laboratory chimps to sanctuaries. Story | Follow @EmilyMFierce
> Big Pharma venture teams back Aileron's shift to early-stage R&D. Article
> Pfizer joins Roche, GSK in $32M round for Mission Therapeutics. More
> In another big cancer setback, Sanofi shutters fedratinib program. News
Pharma News
@FiercePharma: The weekend's best-read special report: Top Pharma Companies by 2012 Revenues. Read | Follow @FiercePharma
@EricPFierce: Pfizer gives BlackBerry the raspberry. Piece | Follow @EricPFierce
@CarlyHFierce: Tufts University report: 71% of revenue from the top 10 best-selling meds last year came from #biotech products. Report | Follow @CarlyHFierce
> GlaxoSmithKline CEO: Big Pharma has to be willing to concede in India. News
> Princeton weighs emergency vaccine campaign with Novartis' Bexsero shot. More
> Takeda's new outsider CFO charged with $1B cost-cutting plan. Article
CRO News
> Post-merger PRA makes another buy, grabbing CRI Lifetree. More
> WuXi boosts outlook as Chinese CRO market swells. Story
> Icon rolls out data visualization tech for adaptive trials. News
> Quintiles expands trial monitoring to slash study costs. Article
> Report: Medpace up for $1.2B sale as CRO M&A heats up. Report
> Catalent cuts ribbon on Chinese trial-supply facility. Item
Biotech IT News
> Falling cost of next-gen sequencing to drive informatics boom. News
> Pfizer takes steps to protect itself from BlackBerry's woes. More
> Validic raises cash to turn mHealth app output into data hose. Piece
> Pfizer finally takes control of Twitter account. Item
> EMA warns of possible delay to final trial data transparency policy. Article